$291.31
3.071.07%
Last update: Nov 6, 4:36 PM
AbbVie Inc
ABBVNYSE
AbbVie (ABBV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
AbbVie (ABBV) last issued guidance on October 30, 2026 for Q4 2026. The company guided earnings per share in the range of $3.83 - $3.87, compared to a consensus EPS estimate of $3.89. AbbVie also guided revenue in the range of $18.4B - $18.4B for the period.
Compared to prior guidance, AbbVie lowered its revenue forecast from a prior range of $67.8B - $67.8B.
AbbVie has issued 67 guidance updates between January 6, 2023 and October 30, 2026. During this period, the company raised its outlook 12 times and lowered it 35 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $3.77 | $3.77 | $2.66 | $2.66 |
| Actual | $3.82 | $3.65 | $2.65 | $2.71 |
| Surprise | +1.33% | -3.18% | -0.38% | +1.88% |
| Revenue | ||||
| Estimate | $17.35B | $16.76B | $14.73B | $16.39B |
| Actual | $17.40B | $16.99B | $15.00B | $16.62B |
| Surprise | +0.30% | +1.37% | +1.84% | +1.37% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $3.88 | $3.44 | $4.09 | $4.22 |
| Revenue | ||||
| Consensus | $18.42B | $16.50B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $3.82 | $3.77 | 1.33 % |
| Q2 | Jul 31, 2026 | $3.65 | $3.77 | -3.18 % |
| Q1 | Apr 29, 2026 | $2.65 | $2.66 | -0.38 % |
| Q4 | Feb 4, 2026 | $2.71 | $2.66 | 1.88 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $17.40B | $17.35B | 0.30 % |
| Q2 | Jul 31, 2026 | $16.99B | $16.76B | 1.37 % |
| Q1 | Apr 29, 2026 | $15.00B | $14.73B | 1.84 % |
| Q4 | Feb 4, 2026 | $16.62B | $16.39B | 1.37 % |
